3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Dermatologic
2
Thoracic
1
Genitourinary
1
Breast
1
Conditions
Prostatic Neoplasms
54
Neoplasms
3
Radiation Injuries
2
Uterine Cervical Neoplasms
1
Recurrence
1
Prostatic Diseases
1
Prostate Cancer With Intermediate Risk
1
Melanoma
1
Lung Neoplasms
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Directly Observed Therapy
1
Carcinoma, Renal Cell
1
Breast Neoplasms
1
Biliary Tract Neoplasms
1
Adenocarcinoma
1
Interventions
pembrolizumab
75
Nivolumab
46
Cyclophosphamide
25
aldesleukin
23
fludarabine
16
atezolizumab
15
Ipilimumab
15
Interleukin-2
14
Radiosurgery
13
Paclitaxel
13
Specimen Handling
12
Magnetic Resonance Spectroscopy
11
Carboplatin
11
fludarabine phosphate
9
Docetaxel
9
durvalumab
8
Cisplatin
8
cemiplimab
7
Bevacizumab
7
Radiotherapy
6
Gemcitabine
6
Biopsy
6
spartalizumab
5
avelumab
5
Pemetrexed
5
Oxaliplatin
5
Immune Checkpoint Inhibitors
5
Filgrastim
5
Cryosurgery
5
Blood Specimen Collection
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Melanoma
×
Brachytherapy
×
Genitourinary
×
Clear all
NCT01777802
2025-08-27
SBRT
Mayo Clinic
Completed
98 enrolled